Immuno-Oncology I: Attacking Cancer Antigens – Exploiting off-the-Shelf and Personalized Vaccines and Triggering of Immunogenic Cell Death

Wednesday, March 9, 2016
9:15 – 10:30am

Immuno-Oncology I: Attacking Cancer Antigens – Exploiting off-the-Shelf and Personalized Vaccines and Triggering of Immunogenic Cell Death

Moderator:

  • Jeffrey M. Bockman, PhD, Vice President, Defined Health

Panelists:

  • Robert Ang, MD, MBA, Chief Business Officer, Neon Therapeutics
  • Ulrike Gnad-Vogt, MD, Chief Medical Officer, CureVac GmbH
  • Stephen T. Isaacs, Chairman and Chief Executive Officer, Aduro BioTech, Inc.
  • Taylor H. Schreiber MD, PhD, Chief Scientific Officer, Heat Biologics Inc.
  • Mai-Britt Zocca, PhD, MSc, Chief Executive Officer, IO Biotech

Register-Button-green